REFERENCES
- Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995;1:55–57.
- WHO. Dengue and Dengue Haemorrhagic Fever. Fact Sheet No. 117, revised May 2008. Geneva: World Health Organization; 2008.
- Nimmannitya S. Dengue hemorrhagic fever: disorders of hemostasis. In: Education Book, IX Congress of the International Society of Haematology Asia-Pacific Division; Bangkok; October 24–28, 1999. International Society of Haematology, Asia-Pacific Division, pp. 184–187.
- Saito M, Oishi K, Inoue S, Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol. 2004;138:299–303.
- Mitrakul C. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg. 1979;26:975–984.
- Boonpucknavig S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg. 1979;28:881–884.
- McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1981;304:1135–1147.
- Cines DB. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008.
- Muller-Eckhardt C. The clinical significance of platelet associated IgG: a study on 298 patients with various disorders. Br J Haematol. 1980;46:123–131.
- Kularante SAM, Walathara C, Mahindawansa SI, Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study. Postgrad Med J. 2009;85:525–529.
- Dimaano ME, Saito M, Honda S, Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg. 2007;77:1135–1138.
- Yadav SP. What else can be done other than vector control to reduce mortality due to Dengue hemorrhagic fever (DHF)? BMJ. 2006. Available at: http://www.bmj.com/content/333/7572/773.4/reply.
- De Castro RA, de Castro JA, Barez MY, Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration anti D (Rh-D) antiglobulin. Am J Trop Med Hyg. 2007;76:737–742.
- Yadav SP, Sachdeva A, Kharya G, Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin. Pediatr Blood Cancer. 2008;51:812–813.
- British Committee for Standards in Haematology. Guidelines for the use of Platelet Transfusions. Br J Haematol. 2003;122:10–23.
- Makroo RN, Raina V, Kumar P, Role of platelet transfusion in the management of dengue patients in a tertiary care hospital. Am J Transf Sci. 2007;1:4–7.
- Scaradavou A, Woo B, Woloski BM, Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997;89:2689–2700.